Biomarker Analysis in Lupus Nephritis Patients

The chapter discusses the identification of proteomic signatures in urine samples from lupus nephritis patients to distinguish different disease types and predict treatment response. It highlights the significance of biomarkers such as neutrophil degranulation and interleukin-16 in active proliferative lupus nephritis and their potential as treatment targets. The comparison between urinary biomarkers and proteinuria in predicting treatment outcomes and kidney function preservation is also explored, emphasizing the role of biomarkers in personalized medicine for lupus nephritis.